Demonstration of Collagenase and Elastase Activities in the Blister Fluids from Bullous Skin Diseases. Comparison Between Dermatitis Herpetiformis and Bullous Pemphigoid  by Olkarinen, Aarne I. et al.
0022-202X/83/81 03-0261$02.00/0 
T HE JOURNAL OF INVESTIGATIVE DERMATOLOGY, 81:261-266, 1983 
Copyright. © 1983 by The Williams & Wilkins Co. 
Vol. 81, No.3 
Printed in U.S.A . 
Demonstration of Collagenase and Elastase Activities in the Blister 
Fluids from Bullous Skin Diseases. Comparison Between Dermatitis 
Herpetiformis and Bullous Pemphigoid* 
AARNE I. 0IKARINEN, M.D., PH.D., JOHN J. ZONE, M.D., A. RAZZAQUE AHMED, M.D ., 
URPO KIISTALA, M.D., PH.D., AND JOUNI UITTO, M.D., PH.D. 
Division of Dermatology, Department of Medicine, University of California School of Medicine, Los Angeles, Harbor-UCLA Medical Center (A JO, 
JU), Torrance, California; Division of Dermatology, Department of Medicine, University of Utah (JJZ), Salt Lake City, Utah; Combined UCLA-
VA Dermatology Programs, University of California (ARA), Las Angeles, California, U.S.A.; Department of Dermatology, University of Helsinki 
(UK), Helsinki, Finland 
We have investigated potential mechanisms for blister 
formation by assaying proteolytic enzymes in the blister 
fluids of patients with various bullous diseases. Blister 
fluids were obtained from patients with dermatitis her-
petiformis (DH), bullous pemphigoid (BP), chronic bul-
lous disease of childhood (CBDC), and pemphigus vul-
garis (PV). The cells were recovered by centrifugation, 
and the supernatants as well as the cell pellets were 
assayed first for collagenase activity using (3 H)proline-
labeled type I collagen as substrate. Collagenase activity 
could be detected in most cases with DH, BP, and CBDC, 
while no activity was found in 2 cases of PV or in 5 
control blister fluids obtained from suction blisters in-
duced in healthy control subjects. Elastase activity was 
assayed in the same blister fluids by using a synthetic 
substrate succinyl-(L-alanyl)a-paranitroanilide or solu-
ble [14C]valine-labeled tropoelastin. High levels of elas-
tase activity were present in all DH patients, while 
lower, but clearly detectable, levels were found in BP, 
CBDC, and PV. The enzyme activity in BP was inhibited 
by Na2EDTA, but not by phenylmethylsulfonyl fluoride 
(PMSF), and Ca2 + stimulated the activity, suggesting 
that the enzyme in BP was a metalloproteinase. In cell-
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Abbreviations: 
BDE: bullous drug eruption 
BMZ: basement membrane zone 
BP: bullous pemphigoid 
CBDC: chronic bullous disease of childhood 
DH: dermatitis herpetiformis 
DTT: dithiothreitol 
ICS: intercellular substance 
Na2EDTA: disodium ethylenediaminetetracetic acid 
NEM: N-ethylmaleimide 
PMSF: phenylmethylsulfonyl fluoride 
PV: pemphigus vulgaris 
SAPNA: succinyl-( L-alanylh-paranitroanilide 
SBTI: soybean trypsin inhibitor 
SDS-PAGE: sodium dodecyl sulfate-polyacrylamide gel electro-
phoresis 
TEN: toxic epidermal necrolysis 
free supernatants of the DH blister fluids, the elastase 
activity was markedly decreased by PMSF, indicating 
that most of the enzyme activity was due to a serine 
protease. The cells recovered from DH blister fluids also 
contained high levels of elastase activity which could be 
inhibited by PMSF but not by Na2 EDTA. Thus, in DH, 
the elastase activity is probably derived from polymor-
phonuclear leukocytes abundantly present in the lesions. 
The results indicate that active proteases are present in 
the blister fluids of skin diseases, and they may play a 
mechanistic role in the blister formation by degrading 
connective tissue components of the dermis and the der-
mal-epidermal junction. 
Bullous diseases are a group of clinical conditions character-
ized by destruction of various components of t he epidermis or 
dermis [2,3). This destruction leads to separation of tissues, 
resulting in the formation of fluid-filled blisters or bullae. The 
events leading to bulla formations are frequently mediated by 
immunologic factors (3,4) . For example, previous studies have 
shown that an IgG fract ion purified from the sera of patients 
with pemphigus vulgaris (PV) is able to elicit acantholysis in 
vitro, mimicking the histopathologic changes found in this 
disease in vivo [5,6). It has been suggested that the acantholysis 
in vitro is independent of complement, and may be mediated 
by activation of skin proteinases (6- 9). In contrast to PV, the 
lgG fraction isolated from t he sera of patients with bullous 
pemphigoid (BP) has fai led to produce t he dermal-epidermal 
separation in vitro [10) . However, incubation of skin explants 
wit h pemphigoid blister fluid results in the separation of the 
epidermis and dermis [ll). This separation was shown to be 
complement-dependent, and it could be inhibited by a 2-ma-
croglobulin, again suggesting that proteolytic enzymes may 
participate in the reaction [ll] . Similar in vitro data are not 
avai lable on dermatitis herpetiformis (DH), although the alter-
native pathway for complement activation has been shown to 
occur in t he skin of these patients [12]. In addition to t hese 
studies, increased collagenase activity may play a role in t issue 
destruction in recessive dystrophic epidermolysis bullosa, a 
heritable disease without immunologic aberrations [13- 15]. 
In this study, we have approached the mechanisms of blister 
formation by assaying proteolytic enzymes in the blister fluids 
of patients with various bullous diseases. The results indicate 
that particularly high levels of collagenase and elastase activity 
a re present in DH. Characterization of these enzymes suggested 
that they are derived from polymorphonuclear leukocytes pres-
ent in the lesions. Thus, these enzymes may directly participate 
in t he blister formation in DH. 
PATIENTS AND METHODS 
Patients 
A total of 22 patients with various forms of bullous diseases were 
included in the study. The clinical data on these patients are present.ed 
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TABLE I. Clinical data on patients with bullous disease 
Patient number 
Immunofluorescence findings 
Diagnosis" Age (years)/sex 
Direct (pattern/ AB)1' Indirect (titer) 
Clinical activity' 
1 DH 
2 DH 
3 DH 
4 DH 
5 DH 
6 DH 
7 BP 
8 BP 
9 BP 
10 BP 
11 BP(C) 
12 BP 
13 BP 
14 BP 
15 PV 
16 PV 
17 CBDC 
18 CBDC 
19 BDE 
20 TEN 
21 Burn blister 
22 Burn blister 
45/M 
62/F 
32/F 
28/F 
68/M 
56/M 
72/F 
74/F 
72/M 
49/M 
66/F 
84/M 
83/F 
76/M 
60/F 
51/F 
6/M 
2/M 
39/F 
42/M 
26/F 
60/M 
Granular /lgA 
Granular/lgA 
Granular/lgA 
Granular/lgA 
Granular/lgA 
Granular/IgA 
BMZ/IgG + C" 
BMZ/IgG 
BMZ/IgG + IgM 
BMZ/lgG 
BMZ/lgG 
BMZ/IgG + C" 
BMZ/IgG 
BMZ/IgG + C" 
ICS/IgG 
ICS/IgG 
Linear/lgA 
Linear/lgA 
1:1280 
0 
1:640 
1:320 
0 
1:160 
1:1280 
1:640 
1:320 
1:640 
Mild 
Moderate 
Severe 
Severe 
Severe 
Severe 
Severe 
Mild, localized 
to 1 foot 
Severe 
Moderate 
Severe 
Moderate 
Moderate 
Moderate 
Severe 
Moderate 
Severe 
Moderate 
Severe 
Severe 
• DH, dermatit is herpetiformis; BP, bullous pemphigoid; BP(C), cicatricial bullous pemphigoid; PV, pemphigus vulgaris; CBDC, chronic 
bullous disease of childhood; BDE, bullous drug eruption; TEN, toxic epidermal necrolysis. 
& The pattern indicates positive immunofluorescence staining with the antibody (AB) tested; BMZ, basement membrane zone; ICS, intercellular 
substance. 
' Clinical activity in DH patients was graded on the basis of the severity of the flare after withdrawal of medication. In PV, BP, CBDC, TEN, 
and BDE patients, clinical activity was graded before treatment. 
in Table I. All of the DH patients had been off all suppressive therapy 
for at least 72 h before collecting the blister fluid samples. From BP, 
PV, and chronic bullous disease of childhood (CBDC) patients blister 
fluids were collected before any specific treatment. For comparison, 
blister fluids were obtained from suction-induced blisters in 5 healthy 
volunteers [16,17] . Fluids from 2 patients with burn blisters, 1 with 
toxic epidermal necrolysis (TEN), and 1 with bullous drug eruption 
(BDE) were also used as controls. 
Preparation of Samples 
The blister fluids were collected with a sterile syringe and stored at 
-20°C. In cases of DH, t he blister fluids were collected with a capillary 
tube and pooled from several blisters. The cells were immediately 
separated by cytocentrifugation, and the relative number of polymor· 
phonuclear leukocytes was determined by counting the cells on micro-
scope slides stained with Wright's stain. The cell pellets and the 
supernatants were stored frozen. 
For enzyme assay, the unfractionated blister fluids or the superna-
tants obtained by a centrifugation were thawed and aliquots were taken 
for collagenase and elastase assays. The cell pellets were homogenized 
with a glass-glass homogenizer in 50 mM Tris-HCl, pH 7.8, at 4°C, and 
the homogenates were centrifuged at 15,000 g for 20 min. The super-
natant was removed and aliquots were taken for enzyme assays. 
Enzyme Assay 
Collagenase activity was determined by incubation of blister fluids 
with 3H-labeled type I collagen, prepared as described previously [18] . 
In a standard incubation, 3-40 1'1 of the blister fluid was incubated in 
10 mM CaCb, 0.15 M NaCl, and 50 mM Tris-HCl, pH 7.6, and containing 
20 l'g/ml bovine serum albumin, in a final volume of 100 1'1, for 4 h, at 
37°C. The reaction was terminated by the addition of Na2EDTA to a 
final concentration of 40 mM . The collagen degradation was determined 
by a method recently developed in our laboratory '[18]. This method is 
based on digestion of the collagen cleavage products by a mixture of 
trypsin and a-chymotrypsin into trichloroacetic acid (TCA)-soluble 
peptides, using conditions under which the undegraded collagen sub-
strate resists proteolysis. The collagen cleavage products, following 
incubation with blister fluids, were also examined by sodium dodecyl 
sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) [19]). The 3H-
labeled collagen peptides were visualized by fluorography [20]. 
For assay of elastase activity, 3 independent methods were used. 
First, a synthetic substrate, succinyl-(L-alanyl)a-paranitroanilide 
(SAPNA) in 1.25 mM concentration, in 50 mM Tris-HCl, pH 7.8, was 
.incubated with the enzyme preparations at 37oC for varying time 
periods [21]. The reaction was monitored by the change in the absorb-
ance at 410 nm, and the enzyme activity was e_xpressed as hydrolysis 
of SAPNA, nmolfh/ml blister fluid . Blanks without added enzyme were 
included in all incubations. The second method for detection of elastase 
activity employed as substrate "C-labeled tropoelastin, prepared by 
incubation of pig aorta explants with ["C]valine. The "C-labeled 
tropoelastin was purified by propanol-butanol extractions [22]. 
Twenty-microliter aliquots of the substrate, containing 3.2 X 103 cpm, 
were incubated with 3-10 1'1 of the enzyme preparation in 0.15 M NaCl, 
50 mM Tris-HCl , pH 7.8, in a final volume of 70 1'1, for 1-8 h, at 37oC. 
The degradation of the substrate was monitored by SDS-PAGE, fo l-
lowed by tluorographic visualization of the radioactive peptides 
[19,20]. The "C-peptides were then studied by scanning the fluoro-
grams with an integrating densitometer (Gelman, ACD 18). The third 
method for detection of elastase activities consisted of incubation of 
blister fluid with orcein-elastin (Millipore Corp.), 2 mg/ml, at 37oC 
[23]. The degradation of the insoluble elastin was monitored by release 
of orcein-containing peptide fragments to 3000 g supernatant of the 
incubate, as detected by absorbance at 590 nm. 
Statistics 
The statistical analyses were performed using Student's two-tailed 
t-test. 
RESULTS 
In the first set of experiments, the activity of collagenase was 
measured in blister fluids employing a highly sensitive and 
specific assay method. The results indicated that significant 
levels of collagenase activity could be detected in blister fluids 
in 3 of 6 patients with DH. Similar levels of collagenase activity 
could be detected in 1 of 2 patients with CBDC, in 5 of 8 
patients with BP, and in the 1 patient with TEN. No detectable 
activity was found in the 2 cases of PV, 1 case of BDE, nor in 
any of the suction blister specimens. 
In 2 cases with DH, the cells were immediately separated 
from the blister fluid by centrifugation. The cell pellets con-
tained over 95% neutrophils in both cases. The collagenase was 
then separately measured in the cell pellet and the supernatant. 
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TABLE II. Distribution of collagenase and elastase activity between cell pellet and the supernatant of blister fluid samples obtained from two 
patients with dermatitis herpetiformis 
Collagenase activity" Elastase activityd 
Patient number" Sample fraction• Units X 10 3/mg nmol/ h/ mg % of total protein Units X 10-
3/ml" % of total protein nmol/ h/ml' 
DH5 Supernatant 2.2 24.2 36.4 14.1 165.0 77.6 
DH 5 Cell pellet 16.7 42.3 63.6 18.6 47.7 22.4 
DH6 Supernatant 4.4 63.8 29.4 13.3 193.0 91.7 
DH6 Cell pellet 67.8 153.1 70.6 7.7 17.4 8.3 
a The numbers refer to Table I . 
• The blister fluids were collected by capillary tubes and the cells and the supernatant were immediately separated by centrifugation as 
indicated in Patients and Methods. Cell pellets consisted of over 95 % neutrophils in both cases. 
c Collagenase activity was assayed by using 3H-labeled type I collagen as substrate; the values refer to the amount of collagen degraded; mean 
of two parallel assays. 
d Elastase activity was assayed by using SAPNA as substrate; the values indicate the hydrolysis of t his substrate, as detected by absorbance 
at 410 nm; mean of two parallel assays. 
"The values indicate the activity in either cell fraction or in the supernatants recovered from 1.0 ml of the original blister fluid. 
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FIG 1. Demonstration of collagenase activity in blister fluids. ["H)-
Proline-labeled type I collagen , purified from chick embryo tendons, 
was incubated with blister fluid or cell homogenate recovered from 
blister fluids by centrifugation. The digests were electrophoresed on 
8% polyacrylamide gels in SDS, and the radioactive peptides were 
visualized by fluorography. The arrows indicate the position of a1(I) 
and a2(I) chains as well as those of the specific degradation products, 
a1 A and a2A, as well as a1 8 and a28 , representing 3/4 and 1/4 fragments 
of the corresponding a-chains , respectively. a, Control without enzyme. 
b, Cell homogenate from patient no. 5 with DH. c, Cell homogenate 
from patient no. 6 with DH. d, Cell-free supernatant from patient no. 
5 with DH. e, Cell-free supernatant from patient no. 6 with DH. f, 
Blister fluid from patient no. 14 with BP. g, Blister fluid from patient 
no. 8 with BP. h, Blister fluid from patient no. 9 with BP. i, Blister 
fluid from a patient with TEN. j, Blister fluid from patient no. 18 with 
CBDC. k, Control digestion with partially purified leukocyte collagen-
ase. 
The results indicated that significant activity could be detected 
in both fractions (Table II) . Calculations of the relative activity 
indicated that 63.6% and 70.6% of the total activity was asso-
ciated with the cell pellet. 
The specificity of the collagenase activity was determined by 
examining the cleavage products by PAGE in SDS. The results 
indicated that collagenase found in patients with DH, BP, 
TEN, or CBDC cleaved the 3H-labeled collagen substrate into 
fragments representing 3/4 and 1/4 length of the intact mole-
cule (Fig 1) . The activity found in the cell pellets of DH blister 
fluids demonstrated the same specificity (Fig 1, lanes band c). 
The collagenase was further characterized by determining 
the effects of various protease inhibitors. Using both assay 
methods, a complete inhibition of the enzyme activity was 
noted in the presence of 20 -mM Na2EDTA and 10% human 
serum. No inhibition was noted in the presence of 1 mM 
phenylmethylsulfonyl fluoride (PMSF). 
The activity of elastolytic enzymes in the blister fluids was 
first measured by using a synthetic substrate, SAPNA. Signif-
icant enzyme activity was detected in 5 patients with DH 
studied (Fig 2). Control experiments indicated that the enzyme 
activity in DH samples measured by hydrolysis of SAPNA, was 
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FIG 2. Elastase act1v1ty in the blister fluids from patients with 
bullous diseases and in suction blisters induced in healthy controls. 
Blister fluids were incubated with SAPNA as substrate, and the enzyme 
activity is expressed as hydrolysis of SAPNA, nmol/ h/ ml blister fluid , 
as monitored by absorbance at 410 nm. The individual values are 
means of 2- 4 parallel samples. The numbers by individual values refer 
to patients in Table I. The mean + 2 SD limit of the healthy controls 
is indicated by t he hatched area. 
linearly proportional to the amount of blister fluid assayed. 
The enzyme activity in the DH group was 219 ± 127 nmol/h/ 
ml (mean ± SD); this value is significantly higher than that of 
5 suction blister controls, the latter value being 1.8 ± 2.5 (p < 
0.005). Detectable enzyme activity was also present in BP 
blister fluids (Fig 2), and the activity linearly increased with 
increasing amounts of sample assayed. The mean ± SD of the 
enzyme activity in the BP group was 16.2 ± 8.3; the value is 
statistically different from the suction blister controls (p < 
0.005). Elevated activity was also found in 2 cases with PV, 2 
cases with CBDC, and in 1 case each of burn blister, BDE, and 
TEN (Fig 2). 
In 2 patients ·with DH, the distribution of elastase activity 
between the cell pellet and cell-free supernatant was also de-
termined·. The results indicated that significant activity was 
detected in both fractions, the relative activity in the cell pellet 
being 22.4% and 8.3 % of the total in the 2 cases, respectively 
(Table II). 
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Since the lack of detectable enzyme activity in suction blister 
controls could be explained by the presence of an inhibitor, 
mixing experiments were subsequently performed. Addition of 
an equal volume of suction blister fluid to either DH or BP 
blister fluid did not change the activity measured without added 
suction blister fluid. Thus, no evidence for an inhibitor for the 
elastase activity was found. 
The elastase activity was also assayed by incubating blister 
fluids with purified tropoelastin, the 68,000 dalton precursor of 
insoluble elastin. Incubation with samples from either DH or 
BP patients, resulted in degradation of tropoelastin (Fig 3). 
Finally, the elastase activity in BP blister fluid from patient 
no. 14 was demonstrated by incubation with insoluble elastin 
abcdefgh 
+ 
FIG 3. Degradation of tropoelastin by blister flu ids from patients 
with DH and BP. Blister fluids were incubated for 120 min at 37•c 
with ["C]valine-labeled tropoelastin purified as described in Patients 
and Methods. The samples were electrophoresed on 12% polyacrylam-
ide gels in SDS, and the radioactive peptides were visualized by fluo-
rography. The migration position of tropoelastin (68,000 daltons) is 
indicated by an arrow. a, Control without enzyme. b, Cell-free super-
natant from patient no. 5 with DH. c, Same as b, but with 20 mM 
Na2EDTA. d, Same as b, but with 1 mM PMSF. e, Cell homogenate 
from patient no. 5 with DH. f , Cell-free supernatant from patient no. 
6 with DH. g, Cell homogenate from patient no. 6 with DH. h, Blister 
fluids from patient no. 14 with BP. i, Same as h, but with 20 mM 
Na2EDTA.j, Same ash, but with 1 mM PMSF. 
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substrate containing orcein. Incubation of 60 ILl of blister fluid 
in a final volume of 1.0 ml released orcein-containing elastin 
fragments, during a 24-h incubation; the increase in the ab-
sorbance at 590 nm was 0.046 per h/ml blister fluid . 
The elastases detected in DH and BP blister samples were 
characterized first by determining the pH optimum of the 
enzymic reaction using SAPNA as substrate. T he results indi-
cated that the enzymes from both sources had the highest 
activity at the neutral pH around 7.4-7.6 (Fig 4). 
T he elastases were further characterized by testing the effects 
of various protease inhibitors on their activity. The activity 
found in BP blister fluids was readily inhibited with 2 mM 
Na2EDTA and 1.0 mM o-phenanthroline (Table III). No inhi-
bition was noted with 0.3 mM PMSF. Addition of 1 mM PMSF 
resulted in an apparent decrease in the enzyme activity, but 
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FIG 4. The effect of pH on the activity of elastase in blister fluids 
from patient no. 5 with DH or patient no. 14 with BP. The buffer in 
pH range 7.0-9.5 was 50 mM Tris-HCl, and pH 6.5 and 6.0 were 
adjusted by the addition of0.1 M citrate (see [41]) . In DH samples, 10-
JJ.l aliquots of cell-free supernatant were used for each point. In BP 
samples, 30-JJ.l a liquots of blister fluids were used for each point. The 
values are expressed as hydrolysis of SAPNA, nmol/h; the individual 
points are means of 2 parallel assays. 
TABLE III. Effects of various protease inhibitors and calcium on the activity of elastase in blister fluids from bullous pemphigoid and dermatitis 
herpetiformis lesions 
Elastase activity" 
Test compound Concentration BP blister fluid DH blister supernatant DH cell pellet added (mM) 
(nmol/h/ m))• (% of control) (nmol/h/ml)• (% of control) (nmol/h/mg)' (% of control) 
None 20.4 100.0 164.0 100.0 18.6 100.0 
Na2EDTA 1.0 12.0 58.8 
Na2EDTA 2.0 5.7 27.9 110.0 67.1 14.9 80.0 
Na2EDTA 4.0 5.1 25.0 70.5 43.0 
o-Phenanthroline 1.0 1.0 4.9 
Ca2+ 1.0 22.8 111.8 
Ca2+ . 5.0 30.8 151.0 163.5 99.7 
Ca2+ + Na2EDTA 5.0 + 20.0 6.9 33.8 
PMSF in propanol 0.3 19.8 97.1 
1% propanold 20.4 100.0 
PMSF in propanol 1.0 11.6 56.9 55.8c 34.0 5.6" 30.0 
3% propanold 11.9 58.3 136.o• 82.9 16.5' 88.7 
NEM 1.0 19.0 93.1 
NEM 5.0 13.3 65.2 109.9 67.0 
DTT 0.2 21.1 103.4 
DTT 1.0 16.9 82.8 
DTT 4.0 12.6 61.8 
SBTI (100 JJ.g/ml) 20.0 98.0 
Human serum (10%) 19.7 96.6 
"Elastase activity was assayed by incubation of SAPNA in 50 mM Tris-HCI, pH 7.8. 
b The values represent hydrolysis of SAPNA, as monitored by absorbance at 410 nm, X h- 1 per ml of the original blister fluid. 
' The values are elastase activity in cell pellet isolated from the DH blister flu ids, as indicated in Patients and Methods, and are expressed per 
mg soluble protein. 
d The fina l concentration of propanol is the same as in the corresponding sample with PMSF. 
• In this experiment, the final conce·ntration of propanol in both samples was 1%. 
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this reduction could be explained by the presence of n-propanol 
used as solvent for the inhibitor (Table III). No inhibition was 
noted with 10% normal human serum, soybean trypsin inhibi-
tor (SBTI) (100 J.Lg/ml), or with N-ethylmaleimide (NEM) or 
dithiothreitol (DTT) in 1.0 mM and 0.2 mM concentrations, 
respectively. A small inhibition with higher concentrations of 
NEM or DTT was noted, however (Table III). 
Since the inhibition of the BP enzyme activity by NazEDTA 
or o-phenanthroline suggested that the enzyme may be a me-
talloproteinase, the effects of Ca2+ on the activity were studied. 
The addition of Ca2+ in 5 mM concentration into the standard 
incubation which did not contain added Ca2+ markedly stimu-
lated the enzyme activity. The Ca2+ -dependent enhancement 
of t he enzyme activity could be abolished by the addition of 20 
mM Na2EDTA (Table III). The inhibition of BP elastase activ-
ity by Na2EDTA was also verified by using tropoelastin as 
substrate. The addition of 20 mM Na2EDTA clearly prevented 
t he degradation on tropoelastin to smaller peptides, while 1 
mM PMSF had no effect (Fig 3, lanes h, i, j). 
Similar inhibitor studies were performed with enzyme prep-
arations obtained from DH blisters. The enzyme activity in 
cell-free supernatant of DH blister fluids was only partially 
inhibited by Na2EDTA in concentrations up to 4.0 mM, and 5 
mM Ca2+ failed to increase the enzyme activity (Table III). In 
contrast, 1 mM PMSF reduced the enzyme activity to 34% of 
the control, while the corresponding amount of propanol used 
as solvent for PMSF reduced the activity only slightly (Table 
III) . Partial inhibition was noted with 5 mM NEM. 
The elastase activity present in the cell pellet recovered from 
DH blister samples was readily inhibited by 1 mM PMSF, but 
not with 4 mM Na2EDTA. These observations were noted using 
both SAPNA (Table III) or tropoelastin as substrate. 
DISCUSSION 
In this study, we have demonstrated that blister fluids ob-
tained from lesions of various bullous diseases contain active 
proteases capable of degrading collagen and elastin. Particu-
larly high levels of proteases were present in DH blister fluids. 
Histologically, the DH lesions are characterized by destruction 
of dermal components leading to formation of papillary mi-
croabscesses and subepidermal blisters [2] . Thus, it is conceiv-
able that the active proteases demonstrated in this study me-
diate the tissue destruction and participate in blister formation 
in some bullous diseases; in others, alternate mechanisms may 
exist. 
Histologically, the DH lesions contain abundant numbers of 
polymorphonuclear leukocytes [2]. Polymorphonuclear leuko-
cytes have been shown to contain a collagenase, which cleaves 
collagen molecules at a specific locus located at three-quarter 
distance away from the amino-terminal end of the molecule 
[24-26]. The leukocyte collagenase is a metalloproteinase which 
is inhibited by metal chelators, such as NazEDTA, and by 
human serum. Similar characteristics were also present in the 
collagenase demonstrated in the DH blister fluids, and conse-
quently, it is possible that polymorphonuclear leukocytes are 
the main source of collagenase activity in these lesions. In 
support of this possibility was the observation that the cell 
pellet, which predominantly consisted of polymorphonuclear 
leukocytes, contained similar collagenase activity as did .the 
cell-free supernatant. 
Polymorphonuclear leukocytes have also been shown to con-
tain an elastase (27-28]. This enzyme is a serine protease and 
can be inhibited by PMSF. In this study, the elastase activity 
found in DH cell pellet was markedly inhibited by PMSF. 
However, the elastase activity detected in the cell-free super-
natant of DH blister specimens was only partially inhibited by 
PMSF, and a significant reduction in elastase activity was 
noted with Na2EDTA. Thus, it appears that the cell-free blister 
fluid contains 2 kinds of elastases. One of them is a serine 
protease probably derived from polymorphonuclear leukocytes. 
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The other elastase may be a metalloprotease, but its origin is 
currently unknown (see below) . 
The release of pro teases from polymorphonuclear leukocytes 
can be elicited by a variety of factors including immune com-
plexes and immunoglobulins [29,30]. The mechanisms of the 
enzyme release from leukocytes in DH are not known, but it is 
possible that local deposition of immunocomplexes containing 
IgA may trigger leukocyte chemotaxis and, subsequently, in-
duce the release of the proteases into the extracellular milieu 
[31,32]. Previous studies have demonst rated that collagenase 
and elastase are located in separate subcellular storage granules 
in polymorphonuclear leukocytes [33]. Thus, the release of 
these 2 proteases may be regulated by different factors, and 
such differential release may occur at different stages of the 
disease process. In support of such differential release mecha-
nism is our observation t hat when cells were separated from 
the extracellular fluid in 2 samples from DH lesions, relatively 
more elastase compared to collagenase was found in the extra-
cellular space. It should be noted that leukocyte elastase, in 
addition to degrading elastin, cleaves type III and type IV 
collagens, which are present in dermis and t he dermal-epider-
mal basement membrane, respectively [34-36]. The leukocyte 
elastase may thus contribute to the destruction of the collagen 
matrix in t he DH lesions. 
The elastase detected in BP blister fluids was different fro m 
that found in DH, in that it was readily inhibited by metal 
chelators, but not by PMSF. The activity was also stimulated 
by the addition of 5 mM Ca2+, suggesting that this enzyme is a 
metalloprotease. The origin of this enzyme in BP blister fluid 
is unknown at t his point. Previously, an elastase-like metallo-
protease has been demonstrated in cultured macrophages [37], 
and cultured skin fibroblasts have been shown to secrete a 
similar enzyme [38]. Also, serum from several patients with 
liver disease [39] and some patients with rheumatoid arthritis 
[ 40] have been shown to contain a Ca2+ -dependent elastase-
like enzyme activity. Similar elastase-like metalloprotease has 
also been suggested to play a role in the degradation of elastic 
fibers in a family with cutis laxa and severe pulmonary emphy-
sema [ 41]. It is possible, therefore, that the elastase activity in 
BP blister fluids is derived from locally proliferating cells, such 
as macrophages or fibroblasts [42]. Alternatively, the enzyme 
is derived from serum of the same patients. These possibilities 
are currently under investigation . 
The authors thank Leslie Anderson for expert technical ass istance. 
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